A kind of chitosan hydrogel preparation and preparation method of dihydromyricetin
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- 海生健康科技(青岛)有限公司
- Publication Date
- 2020-09-29
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
technical field
[0001] The invention relates to the field of pharmaceutical preparations, in particular to a dihydromyricetin-chitosan hydrogel preparation with malic acid as a crosslinking agent and Tween-80 as a gel structure control agent and a preparation method thereof. Background technique
[0002] As we all know, the mortality rate of cancer remains high in the world. At present, the research on its complex pathogenesis has not yet drawn a clear conclusion. Cancer cells originate from the mutation of normal cells in the body. The mutated cells are no longer regulated by the normal apoptosis program and begin to proliferate indefinitely, becoming tumor cells. Cancer is a hot research field for medical workers, and many different types of drugs have been launched for different treatment ideas. Chemotherapy, as the mainstay of cancer treatment, brings hope of cure to many patients. At the same time, anticancer drugs are also a double-edged sword, which has an irreplac...